Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2544-2026

Medline Convenience Kits: 1) LUMBAR PUNCTURE CHOICE Recall

Medline Convenience Kits: 1) LUMBAR PUNCTURE CHOICE, Model Number: DYNDH1215

FDA recall Class II

Ongoing

FDA lists this Class II recall for Medline Convenience Kits: 1) LUMBAR PUNCTURE CHOICE. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2544-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
May 21, 2026
FDA report date
Jul 8, 2026
Quantity in commerce
420 kits
Distribution
See key details
FDA cause
Nonconforming Material/Component

What is being recalled?

Medline Convenience Kits: 1) LUMBAR PUNCTURE CHOICE, Model Number: DYNDH1215

Affected model & UDI checker

Search the exact identifiers published for Z-2544-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
DYNDH1215Medline Convenience Kits: 1) LUMBAR PUNCTURE CHOICECheck source noticeNot specified
Not specifiedMedline Convenience Kits: 1) LUMBAR PUNCTURE CHOICECheck source notice10889942550876
Not specifiedMedline Convenience Kits: 1) LUMBAR PUNCTURE CHOICECheck source notice40889942550877
FDA code information

1) DYNDH1215, UDI-DI: 10889942550876(each), 40889942550877(case), Lot Number: 2025092390

View the original FDA recall notice

Why was this product recalled?

The kits containing Huons Lidocaine HCL Injection USP 1% 10mg/ml 5mL Ampules (Lidocaine Ampules)(OEM). A recall notice was issued by Huons Co., Ltd. for Lidocaine Ampules due to quality issues identified during a recent FDA manufacturing inspection of its drug manufacturing site.

What actions did Medline Industries, LP take?

An URGENT MEDICAL DEVICE RECALL notification letter dated 5/21/26 was sent to customers. REQUIRED ACTION: 1. Immediately check your stock for the affected item number(s) and the affected lot number(s) listed within the recall portal. Quarantine all affected product. 2. Please use the link and the information below to complete your response form. Please list the quantity of affected product you have in inventory on the form. Even if you do not have any affected product in inventory, please complete and submit the form. Website link: https://recalls.medline.com Recall Reference #: R-26-082-FGX2 Recall Code: 3. Upon receipt of your submitted response form, your account will receive over-labels to place on affected inventory, with instructions for your staff to remove and discard the affected component prior to using the kit. These labels will be provided via FedEx overnight, if applicable. 4. If you are a distributor or have resold or transferred this product to another company or individual, you are required by FDA regulations to notify them of this recall communication. Please include your customers quantities on your response form. Upon receipt of your submitted response form, you will receive over-labels to provide to your customers to affix to their affected product. If you have any questions, contact the Recall Department at 866-359-1704 or recalls@medline.com.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology